Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;37(8):10.1002/gps.5777.
doi: 10.1002/gps.5777.

Trazodone and patient outcomes in dementia-Limitations of naturalistic cohort data

Emad Sidhom  1   2 , Mc Stephen Padilla  3 , Jonathan Lewis  4 , Simon White  5 , John T O'Brien  2   5 , Giovanna R Mallucci  1 , Benjamin R Underwood  2   5
Affiliations

Trazodone and patient outcomes in dementia-Limitations of naturalistic cohort data

Emad Sidhom et al. Int J Geriatr Psychiatry. 2022 Aug.

Abstract

The unfolded protein response has been increasingly implicated as an important pathological pathway and target for therapeutic intervention in neurodegeneration. The licensed antidepressant trazodone is one drug which has been proposed to act on this pathway and may therefore be a potential therapy. Previous examination of existing data for patients with dementia prescribed trazodone did not find a signal suggesting a disease modifying effect. Here we add to that literature by examining the electronic patient record of patients with dementia in Cambridgeshire UK. We found that trazodone is rarely prescribed and where it is used it is at a dose less than half that predicted to be disease modifying. We also found that patients prescribed trazodone had higher levels of neuropsychiatric symptoms and were relatively late in the disease course, likely beyond the optimal point for therapeutic intervention. We suggest it is therefore premature to discard potential therapies based on observational data alone, particularly when experimental medicine approaches to examine the effects of trazodone are feasible.

Keywords: Alzheimer's disease; dementia; naturalistic cohort; trazodone; unfolded protein response.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interests relevant to this article.

References

    1. Hughes D, Mallucci GR. The unfolded protein response in neurodegenerative disorders – therapeutic modulation of the PERK pathway [Internet]. FEBS J. Blackwell Publishing Ltd; 2019;286(2):342‐355. https://pubmed.ncbi.nlm.nih.gov/29476642/ - PubMed
    1. Mallucci GR, Klenerman D, Rubinsztein DC. Developing Therapies for neurodegenerative disorders: insights from protein Aggregation and Cellular Stress responses. Annu Rev Cell Dev Biol [Internet]. 2020:36(1):165‐189. https://pubmed.ncbi.nlm.nih.gov/33021824/ - PubMed
    1. Halliday M, Radford H, Zents KAMM, et al. Repurposed drugs targeting eIF2α‐P‐mediated translational repression prevent neurodegeneration in mice. Brain [Internet]. 2017;140(6):1768‐1783. https://academic.oup.com/brain/article/140/6/1768/3737867 - PMC - PubMed
    1. Brauer R, Lau WCY, Hayes JF, et al. Trazodone use and risk of dementia: a population‐based cohort study. PLoS Med. 2019;16(2):e1002728. PMID: 30721226; PMCID: PMC6363148. 10.1371/journal.pmed.1002728 - DOI - PMC - PubMed
    1. La AL, Walsh CM, Neylan TC, et al. Long‐term trazodone use and cognition: a potential therapeutic role for slow‐wave sleep enhancers. J Alzheimer’s Dis [Internet]. 2019;67(3):911‐921. http://pmc/articles/PMC6398835/ - PMC - PubMed

Publication types